Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections.
Nenoff
P
P
Laboratorium für medizinische Mikrobiologie, Strasse des Friedens 8, DE-04579 Mölbis, Germany. info@mykologie-experten.de
Haustein
U-F
UF
Hittel
N
N
D000287:Administration, Topical; D001420:Bacteria, Aerobic / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity; D001421:Bacteria, Anaerobic / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity; D004249:DNA Damage; D024841:Fluoroquinolones / Q000494:pharmacology*; D006094:Gram-Positive Bacteria / Q000187:drug effects / Q000302:isolation & purification* / Q000472:pathogenicity*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008826:Microbial Sensitivity Tests; D011807:Quinolizines / Q000494:pharmacology*; D017192:Skin Diseases, Bacterial / Q000188:drug therapy*; D013237:Stereoisomerism
D024841:Fluoroquinolones; D011807:Quinolizines; C062127:nadifloxacin